- Home
- GOSS vs NNBR Comparison
GOSS vs NNBR Comparison
Compare GOSS & NNBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOSS
- NNBR
- Stock Information
- Founded
- GOSS 2015
- NNBR 1980
- Country
- GOSS United States
- NNBR United States
- Employees
- GOSS N/A
- NNBR N/A
- Industry
- GOSS Biotechnology: Pharmaceutical Preparations
- NNBR Industrial Machinery/Components
- Sector
- GOSS Health Care
- NNBR Industrials
- Exchange
- GOSS Nasdaq
- NNBR Nasdaq
- Market Cap
- GOSS 212.8M
- NNBR 173.8M
- IPO Year
- GOSS 2019
- NNBR 1994
- Fundamental
- Price
- GOSS $1.40
- NNBR $2.89
- Analyst Decision
- GOSS Strong Buy
- NNBR
- Analyst Count
- GOSS 5
- NNBR 0
- Target Price
- GOSS $9.20
- NNBR N/A
- AVG Volume (30 Days)
- GOSS 1.6M
- NNBR 228.9K
- Earning Date
- GOSS 03-04-2025
- NNBR 03-10-2025
- Dividend Yield
- GOSS N/A
- NNBR N/A
- EPS Growth
- GOSS N/A
- NNBR N/A
- EPS
- GOSS N/A
- NNBR N/A
- Revenue
- GOSS $105,322,000.00
- NNBR $470,310,000.00
- Revenue This Year
- GOSS N/A
- NNBR N/A
- Revenue Next Year
- GOSS N/A
- NNBR $0.69
- P/E Ratio
- GOSS N/A
- NNBR N/A
- Revenue Growth
- GOSS N/A
- NNBR N/A
- 52 Week Low
- GOSS $0.50
- NNBR $2.38
- 52 Week High
- GOSS $1.60
- NNBR $5.20
- Technical
- Relative Strength Index (RSI)
- GOSS 67.09
- NNBR 41.16
- Support Level
- GOSS $1.37
- NNBR $3.12
- Resistance Level
- GOSS $1.55
- NNBR $3.52
- Average True Range (ATR)
- GOSS 0.13
- NNBR 0.20
- MACD
- GOSS 0.03
- NNBR -0.01
- Stochastic Oscillator
- GOSS 75.81
- NNBR 1.56
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About NNBR NN Inc.
NN Inc is a diversified industrial company that combines engineering and production capabilities with in-depth materials science expertise to design and manufacture high-precision solutions and components. It operates in two business segments: mobile solutions and power solutions. The mobile solutions segment involves growth in the general industrial and automotive end markets. Its power solutions segment involves growth in the electrical and aerospace and defense end markets. It also operates in China, Mexico, Brazil, Germany, and other countries.